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INTRODUCTION
Left ventricle non-compaction (LVNC) is not frequently prev-
alent among cardiomyopathies. However, it is known to have 
serious consequences such as arrhythmias, sudden cardiac 
death, intracavital and systemic thrombosis, as well as heart 
failure, eventually requiring systolic support or heart transplan-
tation.1-3 There is a complex genetic background responsible 
for LVNC development, which is in part shared with hypertro-
phic and dilative cardiomyopathy (DCM).4,5 Genetic studies 
show that LVNC develops from changes in structure or function 
of the proteins for sarcomere, cytoskeleton and mitochon-
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Purpose: Diagnostic criteria for left ventricular non-compaction (LVNC) are still a matter of dispute. The aim of our present study 
was to test the diagnostic value of two novel diagnostic cardiac magnetic resonance (CMR) parameters: proof of non-compact (NC) 
myocardium blood flow using T2 sequences and changes in geometry of the left ventricle.  
Materials and Methods: The study included cases with LVNC and controls, from a data base formed in a period of 3.5 years (n= 
1890 exams), in which CMR protocol included T2 sequences. Measurement of perpendicular maximal and minimal end diastolic 
dimensions in the region with NC myocardium from short axis plane was recorded, and calculated as a ratio (MaxMinEDDR), 
while flow through trabecula was proven by intracavital T2-weighted hyperintensity (ICT2HI). LVNC diagnosis met the following 
three criteria: thickening of compact (C) layer, NC:C>2.3:1 and NC>20%LV.
Results: The study included 200 patients; 71 with LVNC (35.5%; i.e., 3.76% of CMRs) and 129 (64.5%) controls. MaxMinEDDR in 
patients with LVNC was significantly different  from that in controls (1.17±0.08 vs. 1.06±0.04, respectively; p<0.001). MaxMinED-
DR >1.10 had sensitivity of 91.6% [95% confidence intervals (CI) 82.5–96.8], specificity of 85.3% (95% CI 78.0–90.0), and area un-
der curve (AUC) 0.919 (95% CI 0.872–0.953; p<0.001) for LVNC. Existence of ICT2HI had sensitivity of 100.0% (95% CI 94.9–100.0), 
specificity of 91.5% (95% CI 85.3–95.7), and AUC 0.957 (95% CI 0.919–0.981; p<0.001) for LVNC.  
Conclusion: Two additional diagnostic parameters for LVNC were identified in this study. ICT2HI and geometric eccentricity of 
the ventricle both had relatively high sensitivity and specificity for diagnosing LVNC. 
Key Words:  Left ventricle non-compaction, cardiac magnetic resonance imaging, diagnostic criteria, T2-sequences, maximal to 
minimal end diastolic diameters ratio
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dria.2,6 Fetal development of myocardium includes distinct ph-
ases in terms of time and morphology.7 Sequential process of 
maturation starts with early heart tube in gestational weeks 0–4, 
followed by surfacing of trabeculations in gestational weeks 
4–8, and trabecular remodeling after the 8th week, where tra-
beculations start to fill with compact myocardial layer, finish-
ing with maturation of multilayer spiral system.8 In this manner, 
the extent and severity of LVNC are determined by the timeline 
of process activity, genetic conditions and other surrounding 
factors.7 Postnatal development of trabeculations is somewhat 
more controversial, and could be seen in numerous conditions 
such as congenital heart disease, myocarditis, endocarditis, he-
art surgery and others.8  
Due to complex and perplexing mechanisms involved in the 
development, expression and clinical course of LVNC, imaging 
diagnostic criteria are still a matter of dispute.9 Prominent LVNC 
characteristics include thinning of the compact (C) myocardial 
layer, eminent non-compact (NC) trabeculated layer, which is 
thickened at least 2 to 2.3 times, and proof of blood flow th-
rough trabecula and crypts by Doppler.9-11 Diagnostic yields in-
creased with the use of cardiac magnetic resonance (CMR) im-
aging, due to excellent characteristics in time and space resolut-
ions, tissue characterization, multiplanarity reach independent 
from chest wall anatomy, and MR being the reference standard 
for non-invasive volumetrics.10,12,13
Several studies, using different imaging modalities, found 
non-standardized changes in left ventricle geometry, connect-
ed with LVNC.14 In addition, numerous groups of investigators 
found relationship between the left ventricle geometry, clini-
cal course and prognosis for several heart diseases.15 Our preli-
minary clinical experience, based on a large volume of patients, 
frequently found existent geometric alternations in patients with 
LVNC. Also, we frequently found expressed intracavital hyper-
intensity of non-contrast T2-weighted sequences, which occurs 
due to blood flow through the non-compact layer and myocar-
dial recesses. The aim of our study was to systematically ana-
lyze geometrical changes in the region of non-compact myo-
cardium and intracavital T2 hyperintensity (ICT2HI) in a 
series of LVNC patients, those with clinical suspicion of LVNC, 
and controls. LVNC diagnosis was established using the cur-
rently agreed-upon imaging criteria, occasionally supplement-
ed by the clinical criteria.10,11,16  
 
MATERIALS AND METHODS
Study was conducted in accordance with the Declaration of Hel-
sinki and good clinical practice principles. All the patients were 
included after signing an informed consent form. Study was 
approved by the Hospital’s ethical board. Imaging data for the 
patients fulfilling the LVNC diagnostic criteria were recruited 
from the CMR computer data base, for a period of 3.5 years 
(1890 exams). LVNC diagnosis included the CMR criteria cu-
mulatively consisting of: 1) thinning of compact myocardium 
stratum in end diastole, 2) non-compact to compact myocar-
dium ratio in end diastole (NC:C) of >2.3:1, and 3) trabecula-
tions affecting >20% of the left ventricle myocardium mass.9,10,17 
There were 4 (5.63%) cases with clinically confirmed LVNC 
that did not fulfill one of the three previously mentioned crite-
ria. The latter group included 2 cases not reaching NC:C>2.3:1, 
and 2 other cases not reaching NC>20%LV. 
Matching case control group was made up from healthy in-
dividuals or patients, all of whom had T2-weighted sequences 
within standard protocol (described further on). Control group 
included individuals referred to CMR for diagnostics of struc-
tural heart disease in athletes, suspected or confirmed hyper-
trophic and DCM, suspicion of intracardial thrombus, signifi-
cant arrhythmias without ischemic heart disease, myocarditis 
and pericarditis. Cases with suspicion of LVNC had either non-
thinned compact stratum compared to the remaining part of 
the myocardium in the same short axes slice, increased non-
compact layer with NC:C ratio of 1.9–2.2 and/or NC existing on 
10–19% of the left ventricle mass and were part of the control 
group. For the purpose of subanalysis, the suspecting LVNC 
group was compared with the other patients in the control group. 
Additional subgroup analysis was also performed for patients 
with ICT2HI, and all the control group patients in this assess-
ment were the ones without ICT2HI.
Study did not include patients with significant chest wall de-
formities, cardiac tumors, sarcoidosis, congenital heart disease, 
previous heart surgery, ischemic heart disease [known coro-
nary artery disease with at least one vessel having atheroscle-
rotic lesion >30%, non-negative adenosine stress testing or with 
existent ischemic type of late gadolinium enhancement (LGE)], 
or those who had different imaging protocol (not including T2 
sequences). 
CMR exams were performed on 1.5T Magnetom Avanto, Sie-
mens® (Erlangen, Germany), using ECG gating and respiratory 
control, Body Matrix chest and spine coil. CMR imaging pro-
tocol used in this study consisted of setting localizers, half-Fou-
rier acquisition single-shot turbo spin echo sequences, steady 
state free precession (SSFP) of standard heart 2-, 4-, and 3-cham-
ber planes and 6 mm stack of short axial slices, with adding of 
the right ventricle and its outflow tract in case of any clinical 
questions. Those were followed by short tau inversion recovery 
or turbo spin echo T1 and T2 sequences dark blood, and, fat 
saturation sequences in most cases. The latter was taken on a 
4-chamber view and, in case of suboptimal representation of 
trabecula, additional T2 sequences were done on dedicated 
short axis slices, which was indicated during the exam and de-
pended on the case. Gadolinium contrast was applied in a 0.2 
mL/kg (0.1 mmol/kg) dose. An intravenous bolus of Omnis-
can® (Gadodiamide, GE Healthcare, Carrigtwohill, Ireland) or 
Dotarem® (gadoterate meglumine, Guerbet Group, Villepinte, 
France) was used in the studied exams, followed by inversion 
time recovery scout, with acquisition of the LGE sequences 
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20–30 minutes after the contrast application.
Imaging studies were conducted by two experienced tech-
nicians, performing over 700 CMRs per year. Postprocessing 
analyses were done on a standard software, Siemens AG-NU-
MARIS/4, Syngo MR B17® (Erlangen, Germany), and volumet-
ric measurements were done using Siemens AG-Syngo Con-
sole VA 30 Argus®, by two high throughput cardiologists (over 
400 exams per year) and a radiologist. 
Population and studied groups were analyzed with descrip-
tive statistic and presented as means with standard deviations. 
Group data analyses were done using chi-square. Numeric 
variables were analyzed for differences by the Mann-Whitney 
U-test and, in testing of geometry, ratio to studied etiologies of 
controls was analyzed with Kruskal Wallis. Connections be-
tween the studied CMR parameters and clinical data were done 
by Spearman Rho. Diagnostic potential of T2 hyperintensity 
and maximal to minimal end diastolic diameter ratio (Max-
MinEDDR) for diagnosing LVNC were estimated using a poly-
nomial regression model and receiver operating characteristic 
(ROC) curve analysis. p value less than 0.05 was considered 
significant. Statistical analyses were done by an experienced 
statistician using IBM-SPSS12® ver. 20 (IBM Corp., Armonk, 
NY, USA), MedCalc ver. 12.2® for Windows (MedCalc Software 
Co., Ostend, Belgium), and Statistica 10® for Windows (Stat-
Soft Inc., Tulsa, OK, USA).
RESULTS
Studied sample 
Patients scheduled for magnetic resonance were from our in-
stitution and five tertiary medical centers from different parts 
of the country, including local catchment area of 500000 inhab-
itants and 1.5–2.0×106 from around the country. The study in-
cluded 200 patients referred to CMR diagnostic during a 3.5-year 
period (n=1890 exams). Their age was 46.0±16.3 years [range 
15.2–80.4: 95% confidence intervals (CI) 18.7–69.9] and female 
and male population were 78 (39.0%):122 (61.0%), respectively. 
LVNC meeting the previously mentioned criteria was found in 
71 studied patients (35.5%). Control group was made up from 
129 (64.5%) matching cases, as follows: CMR excluded struc-
tural heart disease (athletes, suspected cardiomyopathy, myo-
carditis and other) in 68 (52.7%) cases, DCM in 26 (20.2%) 
cases, arrhythmogenic right ventricle dysplasia (ARVD) in 5 
(3.9%) cases, hypertrophic cardiomyopathy (HCM) in 16 (16.3%) 
cases, subacute myocarditis in 5 (3.9%) cases and hypertensive 
heart disease in 4 (3.1%) cases. ICT2HI was tested by enhanc-
ing visualization of trabeculations and trabecular blood flow 
from the cavity. ICT2HI was found in 82 (41%) of the studied 
cases, including all the patients with LVNC (n=71; 100%), along 
with 11 (8.5%) cases from the control group. Cases from the 
control group with increased left ventricle trabeculations, in 
the range not sufficient to be diagnosed as LVNC, or cases with 
trabeculations and other types of cardiomyopathy being pre-
dominantly morphological, made up a subgroup of patients 
with suspicion of LVNC (n=46). Of cases with suspicion of 
LVNC, 21 cases (45.7%) did not have structural heart disease 
or cardiomyopathy, 13 cases (28.3%) were with DCM, 8 (17.4%) 
with HCM, 3 (6.5%) with subacute myocarditis and 1 (2.2%) 
had hypertensive heart disease (p=0.198). Group of cases with 
suspicion of LVNC (n=46) was compared to the rest of the con-
trol patients (control 2; n=83). 
Principal differences between 71 patients with LVNC and 129 
matched controls, as well as between those suspected of LVNC 
(n=46) and their controls (control 2) are shown in Table 1. 
Existence and type of LGE correlated with impaired systolic 
function (Rho-CC=0.356; p<0.001), left ventricle end diastolic 
dimension (LVEDD) (Rho-CC=0.140; p=0.049), interventricular 
septum thickness (Rho-CC=0.160; p=0.024), right ventricle end 
diastolic dimension (Rho-CC=-0.157; p=0.026), left ventricle 
end systolic volume (Rho-CC=0.160; p=0.024), left ventricle 
stroke volume (Rho-CC=-0.175; p=0.014) and the patients’ age 
(Rho-CC=0.145; p=0.040). LGE correlated with some of the 
LVNC characteristics, as follows: NC:C>2.3:1 (Rho-CC=0.236; 
p<0.001), NC>20%LV (Rho-CC=0.164; p=0.020) and ICT2HI 
(Rho-CC=0.206; p=0.004), whilst there was no significant cor-
relation of LGE with clinical suspicion of LVNC (Rho-CC= 
0.049; p=0.581).
LVNC diagnostic parameters 
There were 71 patients with LVNC (prevalence 3.8% in the to-
tal sample), with the age of 42.6±17.0 years, (95% CI 18.0–73.5), 
LVEDD was 5.62±0.72 cm (4.65–7.00) and left ventricle ejec-
tion fraction (LVEF) 48.7±12.3% (23.5–63.7). Males predomi-
nated with 42 (59.2%) to 29 (40.8%). As for the principal diag-
nostic criteria, the NC:C ratio >2.3:1 was found in 69 (97.2%) 
and NC>20%LV was also found in 69 (97.2%), while solid layer 
thickness was 0.45±0.13 cm in end diastole vs. 0.78±0.18 cm 
(p<0.001), for patients with LVNC vs. controls, respectively. 
Four patients (2 from each group) did not fulfill two principal 
CMR criteria (NC:C>2.3:1 and NC>20%LV), but their clinical 
data confirmed LVNC. The latters were available at the time of 
CMR (3 patients) and one after the CMR (due to marginally 
highly suspicious report the patient was scheduled for a con-
trol CMR. However, implantable cardiac defibrillator was im-
planted prior to the second exam).
LVEF correlated with parameters of specific diagnostic cri-
teria for LVNC, such as diagnosis of LVNC (Rho-CC=-0.332; 
p<0.001), the ratio of >2.3:1 (Rho-CC=-0.317; p<0.001) and 
share of non-compact myocardium >20% of LV (Rho-CC= 
-0.331; p=0.044). Systolic function also correlated with other 
characteristics of LVNC, such as C-layer thickness (Rho-CC= 
0.186; p=0.009), NC-layer thickness (Rho-CC=-0.379; p<0.001), 
maximal mid apical diameter (Rho-CC=-0.553; p<0.001) and 
minimal diameter (Rho-CC=-0.453; p<0.001), but not signifi-
cantly (within range of statistical tendency; 0.05–0.09) with 
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MaxMinEDDR (Rho-CC=-0.129; p=0.069). There was no sig-
nificant correlation of LVEF with cases with suspicion of LVNC 
(Rho-CC=0.109; p=0.215).
Geometry of the left ventricle in LVNC
Geometric changes in the sphericity of the left ventricle ob-
tained from short axis slices of the NC-affected part of the left 
ventricle pointed toward the left ventricle eccentricity in cases 
of LVNC. The maximal to minimal (perpendicular) end diastol-
ic dimension ratio acquired in mid to apical (trabeculated myo-
cardium section) was 1.17±0.08 in patients with LVNC, which 
was significantly different from the control group 1.06±0.04 
(p<0.001). MaxMinEDDR for LVNC was also different from all 
the other studied etiologies of controls, as follows: LVNC (1.17± 
0.08), ruled out structural heart diseases or cardiomyopathy 
(1.06±0.04), HCM (1.07±0.05), DCM (1.05±0.04), ARVD (1.04± 
Table 1. Group Characteristics and Differences of Patients with LVNC and Controls, as Well as of Cases Suspected of LVNC and Their Controls (Control 2)
 
Controls 
(n=129)
LVNC 
(n=71) Chi-square
Controls 2 
(n=83)
Suspected LVNC 
(n=46) Chi-square
n (%) n (%) n (%) n (%)
Male   80 (62.0) 42 (59.2)   0.691 53 (63.9) 27 (58.7) 0.536
Female   49 (38.0) 29 (40.8)   0.691 30 (36.1) 19 (41.3) 0.536
LVEF<50%   29 (22.5) 33 (46.5) <0.001* 15 (18.1) 14 (30.4) 0.107
NC:C>2.3:1   6 (4.7) 69 (97.2) <0.001* 3 (3.5)   5 (10.9) 0.094
NC>20%LV   0 (0.0) 69 (97.2) <0.001* 1 (1.2) 0 (0.0) 0.294
ICT2HI 11 (8.5)   71 (100.0) <0.001* 3 (3.6)   8 (17.4) 0.035*
Late gadolinium enhancement <0.001* 0.908
No   69 (53.9) 30 (42.3) 46 (54.8) 23 (50.0)
Focal   22 (17.2) 2 (2.8) 14 (16.7)   8 (17.4)
Linear   27 (21.1) 36 (50.7) 16 (19.5) 11 (23.9)
Diffuse 10 (7.8) 3 (4.2) 6 (7.1) 4 (8.7)
 
Controls
(n=129)
LVNC
(n=71)
Mann 
Whitney U
Controls
(n=83)
Suspected LVNC 
(n=46)
Mann 
Whitney U
Mean±SD Mean±SD Mean±SD Mean±SD
Age (years)   47.8±15.7   42.6±17.0   0.031*   47.8±16.4   47.5±14.7 0.849
LVEDD (cm)   5.45±0.98   5.62±0.72   0.039*   5.34±0.99   5.63±0.91 0.061
IVS (cm)   1.14±0.36   0.95±0.17 <0.001*   1.15±0.38   1.10±0.32 0.528
RV (cm)   3.76±0.76   3.51±0.77   0.016*   3.82±0.78   3.64±0.70 0.274
LA (cm2) 27.2±9.1 24.3±5.4   0.081   28.0±10.1 25.7±6.7 0.631
RA (cm2) 24.7±7.8 22.9±6.2   0.195 25.2±8.5 23.8±6.3 0.748
LVEF (%)   55.5±15.0   48.7±12.3 <0.001*   56.4±15.2   53.4±14.5 0.214
EDV (mL) 163.8±83.6 165.2±52.6   0.235 161.1±87.1 168.3±75.7 0.483
ESV (mL)   81.6±81.2   93.3±68.2 <0.001*   79.0±85.2   86.4±71.9 0.319
SV (mL)   86.7±49.0   78.6±26.5   0.110   89.1±58.0   81.5±22.9 0.537
MM (gram) 122.4±49.6 104.7±36.0   0.009* 121.0±49.4 123.9±49.6 0.730
LV trabeculations (%)     7.1±4.85 27.4±5.7 <0.001*   4.8±4.3 11.8±3.8 <0.001*
Compact thickness (cm)   0.78±0.18   0.45±0.13 <0.001*   0.81±0.19   0.71±0.15 0.003*
Non-compact thickness (cm)   0.92±0.45   1.42±0.29 <0.001*   0.78±0.46   1.21±0.29 <0.001*
NC:C ratio   1.26±0.66   3.32±0.95 <0.001*   1.0±0.6   1.8±0.5 <0.001*
Minimal MA EDD (cm)   5.40±0.90   5.20±0.83 <0.001*   5.41±0.95   5.43±0.88 0.811
Maximal MA EDD (cm)   5.71±1.01   5.99±0.85 <0.001*   5.73±1.05   5.78±0.94 0.588
Max to min EDD ratio   1.06±0.04   1.16±0.09 <0.001*   1.06±0.06   1.06±0.04 0.163
ICT2HI, intracavital T-2-weighted hyperintensity; LVNC, left ventricular non-compaction; LVEF<50%, impairment of left ventricle systolic function; NC:C, non-
compact to compact myocardial layer thickness; NC>20%LV, percentage of trabeculations over 20% in total left ventricle mass; LVEDD, left ventricle end diastolic 
dimension in 4-chamber view; IVS, interventricular septum thickness in 4-chamber view; RV, right ventricle end diastolic dimension in 4-chamber view; LA & RA, 
left and right atrial area in square centimeters in 4-chamber view; LVEF, left ventricle ejection fraction; EDV, end diastolic volume; ESV, end systolic volume; SV, stroke 
volume; MM, myocardial mass in end-diastole; MA, mid to apical slices in 6-mm pile stack of short axes; EDD, end diastolic dimension; Max, maximal; Min, minimal. 
Data shown as numbers and percentages or mean with standard deviations.
*Statistically significant values (p<0.05). 
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0.04), subacute myocarditis (1.05±0.01), and hypertensive 
heart disease (1.07±0.02; p<0.001). Other differences of LVNC 
specific characteristics and LV geometry in patients with LVNC 
and controls, and in the group of suspected LVNCs and their 
controls (controls 2) are shown in Table 1. 
MaxMinEDDR correlated more powerfully with LVNC diag-
nostic parameters, attaining greater synergism, than its con-
stituents with LVNC diagnosis (Rho-CC=0.695; p<0.001), C-
layer thickness (Rho-CC=-0.499; p<0.001), NC:C>2.3:1 (Rho-
CC=0.659; p<0.001), and NC>20%LV (Rho-CC=0.675; p<0.001). 
T2-weighted characterization of studied cases
ICT2HI originates from blood flow through the trabeculated 
meshwork of the left ventricle, therefore, it has been the most 
convenient sign available in CMR imaging. ICT2HI was shown 
in all cases of LVNC (n=71; 100%) and small fraction of the con-
trol group patients (n=11; 8.5%). When subanalysis of cases 
was made according to different types of morphology, ICT2HI 
was found in 69/71 (88.5%) patients with LVNC, 4/20 (20.0%) 
patients with HCM, 3/25 (12%) of DCM, 1/5 (20%) of myocardi-
tis, and none in ARVD (0/5) or hypertensive heart disease (0/4). 
None of the patients from the LVNC group had LV-intramyo-
cardial T2 hyperintensity. Characteristics of patients with IC-
T2HI (n=82; 41%) and control group without ICT2HI (group 
control 3; n=118; 59%) are shown in Table 2.
ICT2HI correlated significantly with diagnosis of LVNC (Rho-
CC=0.890; p<0.001) and established diagnostic parameters 
such as NC:C>2.3:1 (Rho-CC=0.824; p<0.001), NC>20%LV (Rho-
CC=0.871; p<0.001) and C-myocardial layer thickness (Rho-
CC=-0.611; p<0.001). ICT2HI correlated with MaxMinEDDR 
(Rho-CC=0.618; p<0.001), whilst its constituents showed weaker 
correlation; MaxEDD (Rho-CC=0.211; p=0.003) and MinEDD 
(Rho-CC=-0.091; p=0.202).
ICTHI correlated with parameters of the left ventricle geom-
etry and function as follows; LVEF (Rho-CC=-0.348; p<0.001), 
end systolic volume (Rho-CC=0.258; p<0.001), stroke volume 
(Rho-CC=0.258; p<0.001), LVEDD (Rho-CC=0.176; p=0.012), 
interventricular septum (Rho-CC=-0.174; p=0.014), right ven-
tricle (Rho-CC=-0.156; p=0.028) and existence of LGE (Rho-
CC=0.206; p=0.004).
Imaging studies on two cases with LVNC and studied diag-
nostic parameters are shown in Figs. 1 and 2. 
Receiver operating characteristic curve analysis of 
LVNC diagnostic parameters
ROC curve analyses for assessment of diagnostic potential 
and cutoff values, estimated by the highest Youden index val-
ue, were done to establish a LVNC diagnosis with new supple-
mentary parameters tested, as well as with the established di-
agnostic parameters.
MaxMinEDDR >1.1009 had sensitivity of 91.6 (82.5–96.8), 
specificity 85.3 (78.0–90.9), positive likelihood ratio (+LR) 6.2 
(5.6–6.9), and -LR 0.10 (0.04–0.2). Area under curve (AUC) was 
0.919 (0.872–0.953), p<0.001. ICT2HI>0 (i.e., existing ICT2HI) 
had sensitivity of 100.0 (94.9–100.0), specificity 91.5 (85.3–
95.7), +LR 11.7 (11.1–12.4), -LR (0.0), and AUC 0.957 (0.919–
0.981), p<0.001.
NC:C>2.2 had sensitivity of 98.6 (92.4–100.0), specificity 
95.4 (90.2–98.3), and +LR 21.2 (20.2–22.2), -LR 0.02 (0.002–0.1). 
AUC 0.986 (0.958–0.997), p<0.001. NC>20%LV had sensitivity 
of 97.2 (90.2–99.7), specificity 100.0 (97.2–100.0), and +LR of ∞, 
-LR 0.028. AUC 0.986 (0.958–0.997), p<0.001. C-layer thickness 
≤0.63 cm had sensitivity of 94.4 (86.2–98.4), specificity 76.0 
(67.7–83.1), and +LR 3.9 (3.5–4.4), -LR 0.07 (0.03–0.2). AUC 0.931 
(0.887–0.962), p<0.001. LVNC diagnostic parameters studied 
in ROC curve are presented cumulatively in Fig. 3.  
Late gadolinium enhancement of LVNC and controls
The most common pattern in LVNC was linear LGE 36 
(50.7%) or none LGE 30 (42.3%), which was significantly dif-
ferent from controls (p<0.001) (Table 1). Conversely, patients 
with suspicion of LVNC did not have different LGE distribu-
tions from their controls [i.e. control 2 (p=0.908)]. LGE corre-
lated with LVNC diagnosis (Rho-CC=0.156; p=0.028), NC:C> 
2.3:1 (Rho-CC=0.236; p<0.001), NC>20%LV (Rho-CC=0.164; 
p=0.020), NC-layer thickness (Rho-CC=0.140; p=0.049), NC:C 
(Rho-CC=0.170; p=0.016) and MaxMinEDDR (Rho-CC=0.143; 
p=0.044). LGE did not correlate significantly with C-layer 
thickness (Rho-CC=-0.128; p=0.071).
Table 2. Characteristics of Patients with ICT2HI vs. the Control Group without ICT2HI (Control 3)
 
Controls 3 (n=118) ICT2HI (n=82)
Chi-square
n (%) n (%)
No structural heart disease/cardiomyopathy 65 (55.1) 3 (3.7)
<0.001*
Left ventricular non-compaction 0 (0.0) 71 (86.6)
Hypertrophic cardiomyopathy 17 (14.4) 4 (4.9)
Dilative cardiomyopathy 23 (19.5) 3 (3.7)
Arrhythmogenic right ventricle disease 5 (4.2) 0 (0.0)
Myocarditis (subacute) 4 (3.4) 1 (1.2)
Hypertensive heart disease 4 (3.4) 0 (0.0)
ICT2HI, intracavital T2 hyperintensity. 
*Statistically significant values (p<0.05).
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DISCUSSION
Current guidelines on the LVNC, with regard to imaging, are 
still open to debate.9,18 Even though it may happen due to vari-
ous clinical expressions of the disease, there is a great clinical 
challenge in everyday practice, in which the prevalence of tra-
beculations found on imaging studies is not negligible, and 
numerous cases become marginal or clinically suspicious.1,19,20 
In the last decade, only a limited number of breakthrough nov-
elties pertaining to LVNC imaging has been reported in litera-
ture. The present study, therefore, tested diagnostic potential 
of two diagnostic parameters that were not previously reported 
by other groups: CMR proof of blood flow through non-com-
pact layer, similar to conceptualization in echocardiography, 
and changes in the geometry of the left ventricle affected by 
trabeculations.21 
In the present study, different types of T2 sequences were 
found to be a very simple and convenient tool for clearly dis-
playing intracavital blood flow through the trabeculated zone 
of myocardium. ICT2HI was found to have very high sensitivi-
ty for LVNC, with all the cases being ICT2HI positive. Specifici-
ty was quite good, since it was found in only 11 (8.5%) patients 
from the control group, and LVNC was excluded in all those 
suspicion cases based on confirmation in cine-SSFP sequenc-
es and an insufficient number of segments affected. ICT2HI 
was positive in cases with increased trabeculations of the left 
ventricle, which in our settings were patients with hypertro-
phic or DCM, those with excluded structural heart disease or 
insufficient criteria for cardiomyopathy, as well as subacute 
myocarditis in one case. Conventional fast/turbo spin echo 
sequences with dark blood preparation and inversion recov-
ery sequences showed higher intensity signal in the region of 
the trabeculated myocardium, originating from muzziness of 
regional blood flow, than in the remaining part of the left ven-
tricle cavity.22-24 This highly intense and spontaneous contrast to 
intracavital blood flow, as well as to compact layer of myocar-
dium, was also of fairly good visibility in cases with arrhyth-
mia. Particular intracavital localization of T2 hyperintensity is 
an advantage in cases with intramyocardial T2 alternated in-
tensities, and also in cases of ischemic heart disease, myocar-
ditis, and infiltrations such as sarcoidosis or malignances.25-28 
Since left ventricular trabeculations are unequally distributed 
Fig. 1. Case of patient with LVNC. Case of LVNC with trabeculations existing on 23.5% of the left ventricle, left ventricle EDD of 6.29 cm, ejection frac-
tion of 40% and confirmed non-compaction. (A) 2-chamber view, cine SSFP. (B) Short axis cine at end diastolic, marked white line showing: 3) Mini-
mal EDD 5.83 cm, 4) Maximal EDD 6.64 cm, giving MaxMinEDDR=1.14; 5) NC-layer thickness 1.63 cm, and 6) C-layer thickness 0.42 cm, with NC:C=3.9; 
4-chamber, cine SSFP. (C) 4-chamber, cine SSFP; showing trabeculations in apical region and lateral wall. (D) 4-chamber, turbo spin echo dark blood 
T2 fat saturation. Blood flow through non-compact layer is shown as hyperintense T2 signal, or the intracavital T-2 weighted hyperintensity, which is 
of high spontaneous contrast to the compact part of the myocardium and to endocavital space. LVNC, left ventricular non-compaction; EDD, end dia-
stolic dimension; SSFP, steady state free precession.
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in different parts of the left ventricle cavity, it is possible that 
non-compact myocardium is undershot or missed due to se-
quential line of acquisition of particular chamber view in cine 
SSFP, especially in case of occurrence of the irregularities of the 
heart rhythms during that particular sequence.29 In patients 
with arrhythmias, we occasionally found different degree of 
NC:C ratio in the same patient, when the particular SSFP se-
quence was repeated due to arrhythmia, or the ECG gating 
was switched to retrospective. In most of those circumstances, 
and those with arrhythmogenic decrease of spatial resolution, 
zones of ICT2HI were of rather fair visibility. In some cases, 
this was the reason to repeat the sequences of dedicated myo-
cardium regions and to increase the diagnostic accuracy of 
trabeculations assessment, as in the patient shown in Fig. 2. 
ICT2HI showed high grade of correlations with diagnostic pa-
rameters for LVNC such as NC:C>2.3 and NC>20%LV, and 
correlated negatively with systolic function of the left ventri-
cle. Most of the conventional parameters, such as left ventricle 
dimensions and volumetrics, showed weak to intermediate 
level of correlation with ICT2HI. 
Changes in the left ventricle geometry within the dedicated 
region affected with non-compact myocardium were also 
found to be connected with LVNC. Both maximal and mini-
mal perpendicular end diastolic dimensions showed signifi-
cant, be it mild or intermediate, grade of correlation with im-
portant diagnostic parameters of LVNC (compact layer thickness, 
NC:C>2.3:1 and NC>20%LV).9,17 On the other hand, their ratio 
(the MaxMinEDDR) attained additional synergism and was 
more powerfully connected, and indicated intermediate to high 
grade correlation with LVNC diagnostic criteria as well as IC-
T2HI. MaxMinEDDR for the patients was in the range of 95% 
CI 1.01–1.25, with LVNC being significantly different than in 
controls (1.17±0.08 vs. 1.06±0.04, respectively; p<0.001). In ad-
dition, MaxMinEDDR of LVNC was significantly different in 
all the heart disease etiologies studied such as dilative or HCM, 
arrhythmogenic right ventricle cardiomyopathy, subacute 
myocarditis, hypertensive heart disease and as well as “healthy” 
controls, in whom the structural heart disease and cardiomy-
Fig. 2. Case two of LVNC. Case of LVNC with trabeculations existing on 23.5% of the left ventricle, ejection fraction of 50% and confirmed non-com-
paction. (A) short axis cine at end diastole, marked white line showing: 1) Maximal EDD 5.33 cm, 2) Minimal EDD 4.79 cm, giving MaxMinEDDR=1.11; 3) 
NC-layer thickness 1.63 cm, and 4) C-layer thickness 0.42 cm, with NC:C=3.9. (B) 4-chamber, cine steady state free precession, showing non-compact 
myocardium in apical and lateral wall. (C) 4-chamber turbo spin echo dark blood T2, showing intracavital hyperintense T2 signal. (D) 4-chamber, in-
version recovery dark blood T2, showing intracavital hyperintense T2 signal. Blood flow through non-compact myocardium is shown as hyperintense 
T2 signal, i.e. ICT2HI, which is of high spontaneous contrast to the compact part of the myocardium and to endocavital space. ICT2HI, intracavital T2-
weighted hyperintensity; MaxMinEDDR, maximal to minimal (perpendicular) end diastolic dimension ratio acquired in mid to apical short axis slices; 
NC:C, non-compact to compact myocardial layer thickness; NC>20%LV, percentage of trabeculations over 20% of total mass of the left ventricle. 
LVNC, left ventricular non-compaction; EDD, end diastolic dimension.
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opathy were ruled out. Clinically, even more significant differ-
ences were found in the cases with clinical suspicion of LVNC, 
pointing MaxMinEDDR as a diagnostic tool to make clear dis-
tinction between the cases with LVNC and those that are clini-
cally suspicious.30 The latter was also confirmed by a lack of 
significant correlations between suspicious LVNC and Max-
MinEDDR, as well as its constituents.  
In conclusion, two additional or supplementary diagnostic 
parameters for LVNC were identified in this study. ICT2HI 
was found to have relatively high specificity and high sensitiv-
ity for LVNC, with all the cases being ICT2HI positive. On the 
other hand, geometric eccentricity of the region with non-
compacted myocardium was also found to be highly sensitive 
and specific for diagnosing LVNC. Furthermore, maximal to 
minimal end diastolic ratio of the patients with LVNC was sig-
nificantly different from the group of cases with clinical suspi-
cion of LVNC, which are commonly found in CMR imaging 
studies. CMR is probably among the best imaging diagnostics 
for patients with LVNC. Further studies on reassessment of 
novel parameters in different populations and settings would 
improve its reproducibility. In addition, studies on LVNC with 
clinical outcomes and patient follow up would be in relation 
to ICT2HI and MaxMinEDDR of an interest.15,31
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Fig. 3. Multiple receiver operating characteristic curve analysis for stud-
ied left ventricular non-compaction diagnostic parameters. ICT2HI, in-
tracavital T-2 weighted hyperintensity; MaxMinEDDR, maximal to mini-
mal end diastolic dimension ratio; NC/C, non-compact to compact 
myocardial layer thickness; NC<20%LV, percentage of trabeculations 
over 20% in total left ventricle mass. ◯ - ROC curve values with the high-
est Youden’s Index.
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